MYC and neuroblastoma: To explore whether the neuroblastoma cells in an MES state could convert to an ADRN state under therapy selection, we treated SK-N-AS xenografts (C-MYC overexpression by a translocated super-enhancer13, known as MES dominant45,46) with indisulam.